Search results
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 4 days agoThe charitable organisation plans to take over lisavanbuilin’s post-access trial programme, allowing...
The charitable organisation plans to take over lisavanbuilin’s post-access trial programme, allowing...